Heparanase Levels Are Elevated in the Plasma of Pediatric Cancer Patients and Correlate with Response to Anticancer Treatment
Authors:
Open Access
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Heparanase: a target for drug discovery in cancer and inflammationBritish Journal of Pharmacology, 2007
- Heparanase Localization and Expression by Head and Neck Cancer: Correlation with Tumor Progression and Patient SurvivalNeoplasia, 2006
- Heparanase Expression in Malignant Salivary Gl, Tumors Inversely Correlates with Long-Term SurvivalNeoplasia, 2006
- An ELISA method for the detection and quantification of human heparanaseBiochemical and Biophysical Research Communications, 2006
- SERUM VASCULAR ENDOTHELIAL GROWTH FACTOR AS A SIGNIFICANT MARKER OF TREATMENT RESPONSE IN PEDIATRIC MALIGNANCIESPediatric Hematology and Oncology, 2005
- A Synthetic Heparanase Inhibitor Reduces Proteinuria in Passive Heymann NephritisJournal of the American Society of Nephrology, 2004
- Processing and activation of latent heparanase occurs in lysosomesJournal of Cell Science, 2004
- Heparanase expression during normal liver development and following partial hepatectomyThe Journal of Pathology, 2004
- Role of Heparanase in Platelet and Tumor Cell Interactions with the Subendothelial Extracellular MatrixSeminars in Thrombosis and Hemostasis, 1987
- Murine macrophage heparanase: Inhibition and comparison with metastatic tumor cellsJournal of Cellular Physiology, 1987